1,720,968 research outputs found

    Not all placebos are equally pleasing

    No full text
    David W. Sturdee, Alastair H. MacLenna

    Is combined estrogen/progestogen hormone therapy worth the risk?

    No full text
    David W. Sturdee and Alastair H. MacLenna

    Evolution and revolution at the menopause

    No full text
    David W. Sturdee and Alastair H. MacLenna

    Prevention of osteoporosis is still a valid aim for hormone therapy

    No full text
    David W. Sturdee and Alastair H. MacLenna

    The pendulum swings back; estrogen is now beneficial if started at the right time

    No full text
    David W. Sturdee and Alastair H. MacLenna

    Reducing the problems of the progestogen

    No full text
    David W. Sturdee and Alastair H. MacLenna

    How low can you go?

    No full text
    David W. Sturdee and Alastair H. MacLenna

    IMS Updated recommendations on postmenopausal hormone therapy

    No full text
    copyright 2007 International Menopause Society Issued on behalf of the Board of the International Menopause Society by; Amos Pines (President); David W. Sturdee (General Secretary); Martin H. Birkhuser (Treasurer); Hermann P. G. Schneider; Marco Gambacciani; Nick Pana

    Changes in activity level in women aged 40-80 years

    No full text
    Objectives The purpose of this study was to report habitual physical activity levels in women and document the change in level of activity and factors affecting this change over a 5-year period. Methods A 5-year prospective cohort design was used. Women aged 40-80 years, living independently in the community, were recruited via the electoral role. The effects were investigated, first, of age, activity level, history of falls, number of comorbidities and medications, body mass index and stability at baseline on change in activity level and, second, change in these demographics on activity level over the study period. Results Data from 459 women who completed our study are reported. Only activity level and body mass index at baseline significantly affected change in activity level (p < 0.000). Change in activity level was not influenced by change in demographics over the study period. The forties and fifties cohorts accounted for the baseline body mass index effect on activity change (p < 0.04). In the forties cohort, number of medical conditions at base line (p < 0.03) and, in the sixties cohort, increase in number of medical conditions (p = 0.0 11) affected activity level change. Conclusions Activity level at baseline and body mass index in younger women were most likely to affect change over time. Being unsteady or having already fallen did not stimulate change
    corecore